Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4DDK

Pantothenate synthetase in complex with 1,3-benzodioxole-5-carboxylic acid

Summary for 4DDK
Entry DOI10.2210/pdb4ddk/pdb
Related4DDH 4DDM
DescriptorPantothenate synthetase, 1,3-benzodioxole-5-carboxylic acid, GLYCEROL, ... (6 entities in total)
Functional Keywordsfragment-based drug discovery, alpha beta/adenine nucleotide alpha hydrolase-like, pantoate and b-ala binding, ligase-ligase inhibitor complex, ligase/ligase inhibitor
Biological sourceMycobacterium tuberculosis
Cellular locationCytoplasm (Potential): P0A5R0
Total number of polymer chains2
Total formula weight64163.33
Authors
Silvestre, H.L. (deposition date: 2012-01-18, release date: 2013-02-13, Last modification date: 2023-09-13)
Primary citationSilvestre, H.L.,Blundell, T.L.,Abell, C.,Ciulli, A.
Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
Proc.Natl.Acad.Sci.USA, 110:12984-12989, 2013
Cited by
PubMed Abstract: In fragment-based drug discovery, the weak affinities exhibited by fragments pose significant challenges for screening. Biophysical techniques are used to address this challenge, but there is no clear consensus on which cascade of methods is best suited to identify fragment hits that ultimately translate into bound X-ray structures and provide bona fide starting points for synthesis. We have benchmarked an integrated biophysical approach for fragment screening and validation against Mycobacterium tuberculosis pantothenate synthetase. A primary screen of 1,250 fragments library was performed by thermal shift, followed by secondary screen using one-dimensional NMR spectroscopy (water ligand observed gradient spectroscopy and saturation transfer difference binding experiments) and ultimate hit validation by isothermal titration calorimetry and X-ray crystallography. Our multibiophysical approach identified three distinct binding sites for fragments and laid a solid foundation for successful structure-based elaboration into potent inhibitors.
PubMed: 23872845
DOI: 10.1073/pnas.1304045110
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

244349

数据于2025-11-05公开中

PDB statisticsPDBj update infoContact PDBjnumon